Two Sigma Investments
SGMO

Two Sigma Investments’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Two Sigma Investments’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.55M Buy
6,270,441
+1,514,446
+32% +$603K ﹤0.01% 2957
2025
Q4 		$2M Buy
4,755,995
+2,276,809
+92% +$1.21M ﹤0.01% 2430
2025
Q3 		$1.67M Buy
2,479,186
+1,602,107
+183% +$864K ﹤0.01% 2250
2025
Q2 		$475K Buy
877,079
+90,334
+11% +$53.6K ﹤0.01% 2608
2025
Q1 		$516K Sell
786,745
-225,895
-22% -$239K ﹤0.01% 2509
2024
Q4 		$1.03M Buy
1,012,640
+698,296
+222% +$1.28M ﹤0.01% 2157
2024
Q3 		$272K Sell
314,344
-228,850
-42% -$168K ﹤0.01% 2710
2024
Q2 		$195K Sell
543,194
-11,661
-2% -$6.3K ﹤0.01% 2737
2024
Q1 		$372K Sell
554,855
-1,619,278
-74% -$1.17M ﹤0.01% 2462
2023
Q4 		$1.18M Buy
2,174,133
+1,277,706
+143% +$589K ﹤0.01% 1979
2023
Q3 		$538K Sell
896,427
-340,792
-28% -$365K ﹤0.01% 2239
2023
Q2 		$1.61M Buy
1,237,219
+306,726
+33% +$419K ﹤0.01% 1615
2023
Q1 		$1.64M Sell
930,493
-155,462
-14% -$444K ﹤0.01% 1524
2022
Q4 		$3.41M Sell
1,085,955
-85,021
-7% -$330K 0.01% 1054
2022
Q3 		$5.74M Buy
1,170,976
+442,146
+61% +$2.27M 0.02% 705
2022
Q2 		$3.02M Buy
728,830
+368,438
+102% +$1.59M 0.01% 980
2022
Q1 		$2.09M Sell
360,392
-123,948
-26% -$737K 0.01% 1333
2021
Q4 		$3.63M Buy
484,340
+46,249
+11% +$402K 0.01% 1415
2021
Q3 		$3.95M Sell
438,091
-98,757
-18% -$976K 0.01% 1412
2021
Q2 		$6.43M Sell
536,848
-380,884
-42% -$4.31M 0.01% 1048
2021
Q1 		$11.5M Sell
917,732
-336,411
-27% -$4.53M 0.03% 648
2020
Q4 		$19.6M Sell
1,254,143
-525,167
-30% -$6.15M 0.06% 378
2020
Q3 		$16.8M Sell
1,779,310
-346,225
-16% -$3.74M 0.06% 346
2020
Q2 		$19M Buy
2,125,535
+1,177,731
+124% +$10.9M 0.09% 224
2020
Q1 		$6.04M Buy
947,804
+477,097
+101% +$3.54M 0.05% 422
2019
Q4 		$3.94M Buy
470,707
+310,214
+193% +$2.85M 0.01% 1110
2019
Q3 		$1.45M Buy
+160,493
New +$1.8M ﹤0.01% 1678
2018
Q2 		– Sell
-80,369
Closed -$1.53M – 3608
2018
Q1 		$1.53M Sell
80,369
-114,350
-59% -$2.44M 0.01% 1718
2017
Q4 		$3.19M Buy
194,719
+181,770
+1,404% +$2.7M 0.01% 1164
2017
Q3 		$194K Sell
12,949
-127,279
-91% -$1.41M ﹤0.01% 2596
2017
Q2 		$1.23M Buy
+140,228
New +$900K ﹤0.01% 1758
2016
Q1 		– Sell
-22,226
Closed -$203K – 3090
2015
Q4 		$203K Buy
+22,226
New +$171K ﹤0.01% 2466
2015
Q3 		– Sell
-69,303
Closed -$769K – 2672
2015
Q2 		$769K Buy
+69,303
New +$894K ﹤0.01% 1834
2015
Q1 		– Sell
-101,563
Closed -$1.54M – 2829
2014
Q4 		$1.54M Sell
101,563
-15,518
-13% -$188K 0.01% 1156
2014
Q3 		$1.26M Buy
117,081
+45,393
+63% +$593K 0.01% 1000
2014
Q2 		$1.09M Buy
+71,688
New +$1.03M ﹤0.01% 1274

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Two Sigma Investments's SGMO Position: Q1 2026 in Review

Two Sigma Investments increased its SANGAMO THERAPEUTICS INC (SGMO) stake by 32% in Q1 2026, buying an estimated $603K and bringing the position to 6,270,441 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2957.

Two Sigma Investments first reported a position in SGMO in Q2 2014 and has held it in 36 quarters since. The position peaked at $19.6M in Q4 2020. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Two Sigma Investments held 6,270,441 shares of SANGAMO THERAPEUTICS INC worth $1.55M as of Q1 2026.
  • Two Sigma Investments bought 1,514,446 SANGAMO THERAPEUTICS INC shares in Q1 2026, an estimated $603K.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2957 holding.
  • Two Sigma Investments first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and has held it in 36 quarters since.
  • Two Sigma Investments's SANGAMO THERAPEUTICS INC position peaked at $19.6M in Q4 2020.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.